These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Obiltoxaximab (Anthim) for inhalation anthrax. Med Lett Drugs Ther; 2018 Sep; 60(1555):150-151. PubMed ID: 30383733 [No Abstract] [Full Text] [Related]
6. Absence of mycoplasma contamination in the anthrax vaccine. Hart MK; Del Giudice RA; Korch GW Emerg Infect Dis; 2002 Jan; 8(1):94-6. PubMed ID: 11840996 [TBL] [Abstract][Full Text] [Related]
7. Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed. Pittman PR; Cavicchia MA; Kingsbury JL; Johnson NA; Barrera-Oro JG; Schmader T; Korman L; Quinn X; Ranadive M Vaccine; 2014 Sep; 32(39):5131-9. PubMed ID: 24837771 [TBL] [Abstract][Full Text] [Related]
8. The development of new vaccines against Bacillus anthracis. Baillie L J Appl Microbiol; 2001 Oct; 91(4):609-13. PubMed ID: 11576296 [No Abstract] [Full Text] [Related]
9. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices. J Toxicol Clin Toxicol; 2001; 39(1):85-100. PubMed ID: 11327233 [TBL] [Abstract][Full Text] [Related]
10. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis. Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170 [TBL] [Abstract][Full Text] [Related]
11. [Progress on the vaccine for anthrax]. Zhan DW; Wang P; Wang LC; Zhang ZS Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):149-52. PubMed ID: 15847185 [TBL] [Abstract][Full Text] [Related]
13. Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule. Longstreth J; Skiadopoulos MH; Hopkins RJ Expert Rev Vaccines; 2016 Dec; 15(12):1467-1479. PubMed ID: 27792416 [TBL] [Abstract][Full Text] [Related]
14. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy. Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452 [TBL] [Abstract][Full Text] [Related]